Tejnaksh Healthcare (BOM:539428) Tariff Resilience Score: 0/10 (As of Aug. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:539428 Tejnaksh Healthcare Ltd BOM:539428
68 GF Score
Price ₹13.38
GF Value ₹20.93
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Tejnaksh Healthcare Tariff Resilience Score?

Tejnaksh Healthcare has the Tariff Resilience Score of 0, which implies that the company might have .

Tejnaksh Healthcare has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Tejnaksh Healthcare might have .

Tejnaksh Healthcare  (BOM:539428) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Tejnaksh Healthcare Tariff Resilience Score Related Terms

BOM:539428
68GF Score
Tejnaksh Healthcare Ltd BOM:539428
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Tejnaksh Healthcare (BOM:539428) Overvalued in 2026?

Based on GuruFocus' analysis, Tejnaksh Healthcare stock appears to be undervalued. The current stock price of ₹13.38 is trading 36.1% below its estimated GF Value™ of ₹20.93. GuruFocus considers Tejnaksh Healthcare to be Possible Value Trap.

Key valuation signals for BOM:539428:

  • Tariff Resilience Score: 0
  • GF Value™: ₹20.93 vs. price of ₹13.38 (36.1% below fair value)
  • GF Score™: 68/100 with 4 warning signs

No single metric tells the full story. See the BOM:539428 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tejnaksh Healthcare Business Description

Address Institute of Urology, Sakri Road, Dhule, MH, IND, 424 001
Tejnaksh Healthcare Ltd is engaged in the provision of hospital and healthcare services. Geographically, it operates only in India. The company has a single operating segment, namely health care services. The company domains include Urology Hospitals; Nephrology Hospitals; Dental Clinics; Healthcare Equipment, Research and Development and others. It generates maximum revenue from fees charged under contract for inpatient and outpatient hospital services and also includes sale of medical and non-medical items. Hospital services include charges for accommodation, medical professional services, pathology and pharmaceutical goods used in treatments given to patient.
68GF Score

Get the complete analysis for BOM:539428

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹13.38
Price
₹20.93
GF Value